Abstract

Efficacy of Clopidogrel Drug and Response Prediction with Special Reference to Recent Paradigm Shift

The role of clopidogrel in disruption of platelet aggregation is well known. The variability in clopidogrel response is a well-documented phenomenon and has been widely addressed through pharmacogenomics. CYP2C19 has been considered as genetic predictor of clopidogrel response. Owing to the inter-individual variations, CPIC (Clinical Pharmacogenetics Implementation Consortium) had issued guidelines in compliance with FDA. However, based on the genetic proofs clinical utility is more or less unsuccessful. The use of miRNAs to predict drug response and the introduction of miRNA-pharmacogenomics holds promise to bridge this gap and may improves the clinical utility by synergistically addressing the issue through genetic variations and miRNAs.


Author(s):

Anu Radha Sharma and Padmalatha S Rai*



Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+
30+ Million Readerbase
Recommended Conferences
Flyer image
Abstracted/Indexed in
  • Google Scholar
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • MIAR
  • ResearchGate
  • University Grants Commission
  • Secret Search Engine Labs

tempobet

tempobet giriş

tempobet giriş

tipobet süpertotobet yeni adres süperbahis 747 güvenilir bahis siteleri telefonda sex sohbet